HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation.

CONCLUSION: Treating the entire eligible HCV population would lead to significant benefits and savings in managing liver-related diseases and their direct costs, opening opportunities to re-think new settings for the future organisation of liver disease management in the regional health system. PMID: 30321071 [PubMed - as supplied by publisher]
Source: Expert Review of Pharmacoeconomics and Outcomes Research - Category: Health Management Tags: Expert Rev Pharmacoecon Outcomes Res Source Type: research